Clinical Trial

VENTURI (VENTilation Using Respiratory Imaging)

Study acronym: VENTURI
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of the study is to enroll participants with uncontrolled asthma to evaluate the large and small airways and drug delivery utilizing two study drugs: * Beclometasone dipropionate/Formoterol fumarate dihydrate/Glycopyrronium bromide (BDP/FF/G) or Trimbow * Fluticasone furoate/Umeclidinium/Vilanterol (FluF/UMEC/VI ) or Trelegy Ellipta
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-14
Trial Details
NCT Number NCT07282886
Lead Sponsor University of Alabama at Birmingham
Conditions Asthma
Enrollment 20 participants
Start Date 2026-03-15
Primary Completion 2028-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-13